Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Publicized $ Settlement or Trial Victory...

Anything short of a publicized $ settlement or trial victory will indicate a continuation of the status quo. There is absolutely no reason as to why we can not announce a T3 license fee if we are successful during litigation given the fact we announced a Fujitsu 32 million dollar license and an HP 20 million dollar license several years ago when we were supposedly less strong.

By not announcing there are only a few scenarios that could be true.

1. TPL wants to hoard as much MMP dollars with possible PTSC approval. The BOD has nothing to lose as they have virtually no relation to the share price outside of free options.

2. The MMP has lost significant strength in generating revenue.

In my opinion those are the two general explanations for not announcing as most explanations could be classified under the above set. There would probably be time for two more legal challenges against infringers, or maybe more time if we get a favorable Markman result.

The Markman hearing is going to be THE most important event in the history of the MMP. As the USPTO challenges are all but done, I only hope PTSC management are focusing on their SP as their primary responsibility.

GLTAL

Share
New Message
Please login to post a reply